FTC approves modifications to Boston Scientific divestiture agreement

Reuters

– The U.S. Federal Trade Commission said it has approved certain modifications to medical device company Boston Scientific Corp’s divestiture agreements.

“The FTC approved these agreements and incorporated them into its order as part of a consent agreement it required in 2019, when Boston Scientific acquired medical equipment and pharmaceutical supplier BTG plc,” the FTC said in a statement https://bit.ly/3Bv08z0 on Friday.

As a condition of Boston Scientific’s acquisition of BTG, the FTC required it to divest to Varian Medical Systems its Drug Eluding Beads (DEBs) and bland beads business, the FTC said.

(Reporting by Kanishka Singh in Bengaluru; Editing by Chris Reese)

tagreuters.com2022binary_LYNXMPEI1H0YQ-BASEIMAGE


You appear to be using an ad blocker

Shore News Network is a free website that does not use paywalls or charge for access to original, breaking news content. In order to provide this free service, we rely on advertisements. Please support our journalism by disabling your ad blocker for this website.